Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    FDA Clears BioFire Ebola Diagnostics for Emergency Use

    By Global Biodefense StaffOctober 27, 2014
    Ebola virus in Democratic Republic of Congo
    Image courtesy of NIAID
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Food and Drug Administration (FDA) has authorized emergency use of two BioFire Defense diagnostic tests to detect the Ebola Zaire virus in individuals with signs and symptoms of Ebola virus infection, or who are at risk for exposure.

    The BioFire Defense FilmArray Biothreat-E test is for use by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform moderate complexity tests and by laboratories certified under CLIA to perform high complexity tests.

    The FilmArray Biothreat-E Emergency Use Authorization (.pdf) for the test enables hospitals with laboratories that fit these characteristics to conduct a PCR test for Ebola in-house, without having to send the sample to an outside lab.

    More than 300 U.S. hospitals already use FilmArray systems for multiplexed respiratory and gastrointestinal diagnostics. The hospitals will simply add the BioThreat-E assay kits to test for the Ebola Zaire virus on those machines.

    Besides the commercial test, the FDA gave emergency authorization (.pdf) for BioFire’s FilmArray NGDS BT-E for laboratories designated by the Department of Defense (DoD).

    “We believe that a fast, easy-to-use and accurate Ebola test will help in the fight against this horrible virus,” said Kirk Ririe, chief executive officer of BioFire Defense.

    In August 2014, the FDA also approved emergency use for the DoD developed EZ1 rRT-PCR Assay for several validated platforms, including BioFire Defense’s Joint Biological Agent Identification and Diagnostic System (JBAIDS).

    In Spring 2014, BioFire Defense was awarded the Next Generation Diagnostic System (NGDS) Technology Development contract by the DoD after 12 months of competitive prototyping. The NGDS program will develop and deliver the new standard of biothreat detection to the US Department of Defense, replacing JBAIDS.

    Ebola Emergency Use Authorization Emerging Threats
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDARPA Awards 12.2M for Monoclonal Antibody Research
    Next Article Shorter TB Treatment Not A Successful Alternative

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.